Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Cenobamate Impact on Cognition in Tuberous Sclerosis Complex
February 2026
In adults with tuberous sclerosis complex, add-on cenobamate improved executive function, quality of life, and stress.
Read more
26 Nov 2024
Clonazepam Recall Due To Strength Mislabeling
Clonazepam has been recalled due to potential product carton strength mislabeling. Endo Pharmaceuticals (Malvern, Pennsylvania) has issued a voluntary, nationwide recall of a specific lot of Clonazepam Orally Disintegrating Tablets (USP, C-IV).
24 Nov 2024
Long-Term Cognitive Impact of Anti-NMDAR Encephalitis
Long-term cognitive and psychosocial challenges faced by individuals recovering from anti-NMDAR encephalitis, despite many regaining independence, have been highlighted in a recent study.
21 Nov 2024
High Fitness Cuts Dementia Risk By 35%
A new study in the UK Biobank suggests that high cardiorespiratory fitness (CRF) can significantly reduce dementia risk and delay its onset, even in individuals with a genetic predisposition to the condition.
16 Nov 2024
Cholesterol Fluctuations Accelerate Dementia: Early Intervention Opportunity
Significant fluctuations in cholesterol levels, unrelated to changes in medication, may serve as an early indicator of increased dementia risk in older adults, according to a recent press release from American Heart Association Scientific Sessions 2024.
13 Nov 2024
The Teen Brain’s Secret Weapon Against Pain?
Resilience in adolescents with juvenile fibromyalgia (JFM) may significantly alleviate emotional symptoms, providing fresh insights for clinicians treating this complex chronic pain condition.
11 Nov 2024
How Does Asthma Alter Children’s Memory Development?
Children with asthma, particularly those with an early onset, may experience slower memory development and face challenges in cognitive functions.
7 Nov 2024
Poor Sleep Doubles Cognitive Decline Risk
A recent study highlights how sleep disturbances, especially daytime dysfunction, excessive sleepiness and lower enthusiasm, may significantly increase the risk of motoric cognitive risk (MCR) syndrome in older adults.
6 Nov 2024
Autism Spectrum Disorder: AI Reveals Distinct Clinical Profiles
A recent study has leveraged advanced machine learning to uncover three distinct autism spectrum disorder (ASD) subtypes, providing a novel view of the condition’s brain network variations.
Loading posts...
« Previous
1
…
29
30
31
32
33
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View